2024年消费者健康洞察呼吸系列报告—哮喘炎篇预览版

O2O and B2C Shopping Trends

O2O and B2C e-commerce show significant growth from 2021 to 2024, with N=14540 surveyed in 2024. O2O increased by +34.2% year-over-year, reflecting higher adoption, while B2C saw +10.1% growth, particularly among age groups 18-35. Channel preferences vary by age: younger groups prefer B2C for convenience, while O2O is favored for its access to professional recommendations.

Respiratory Health Dominance

Breathing problems are the leading health concern in 2024, noted by 85.2% of N=15273 respondents. Symptoms like dry cough and nasal issues rose post-pandemic; common treatments include inhalers and oral medications. Drug usage trends show 60.8% opting for quick relief, with 36.5% seeking alternatives for chronic conditions like asthma. Patient demands for non-pharmacological options and timely care are high, but unmet needs include inadequate support for managing flare-ups.

Patient Behavior Analysis

In 2021-2024, survey data (N=2000-14540) reveal increased self-medication: 94.4% of patients treat symptoms without doctor visits in 2024. Demographics show 18-35-year-olds leading in digital health adoption, while older groups prefer in-person consultations. Medication choices differ by condition duration and severity, with 44.6% using single brands and 23.6% exploring alternatives for asthma. Store recommendations (O2O) drive conversions in some cases, but users prioritize direct purchases or online channels for cost savings.

Channel Preferences and Evaluations

Across age groups (18-35, 36-45, etc.), B2C appeals for ease of access, but O2O is judged higher for professional advice. Spending patterns: B2C users shop more frequently with moderate spend, while O2O offers better integration with healthcare facilities. Key unmet needs include reducing wait times and improving affordability. Data comparisons from 2023-2024 show shifts in brand loyalty and channel efficiency, with O2O facing slight decline in 2024 but remaining a vital option.